Akari Therapeutics Plc Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Akari Therapeutics Plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Akari Therapeutics Plc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$687K, a 79% increase year-over-year.
  • Akari Therapeutics Plc annual Nonoperating Income (Expense) for 2023 was $240K.
  • Akari Therapeutics Plc annual Nonoperating Income (Expense) for 2022 was -$1.31M, a 526% decline from 2021.
  • Akari Therapeutics Plc annual Nonoperating Income (Expense) for 2021 was -$210K, a 123% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $240K +$1.55M Jan 1, 2023 Dec 31, 2023 8-K 2024-09-06
2022 -$1.31M -$1.1M -526% Jan 1, 2022 Dec 31, 2022 8-K 2024-09-06
2021 -$210K -$1.11M -123% Jan 1, 2021 Dec 31, 2021 20-F 2023-05-01
2020 $899K +$782K +669% Jan 1, 2020 Dec 31, 2020 20-F 2023-05-01
2019 $117K -$169K -59.1% Jan 1, 2019 Dec 31, 2019 20-F 2022-05-16
2018 $286K -$2.1M -88% Jan 1, 2018 Dec 31, 2018 20-F 2021-04-21
2017 $2.38M -$6.72M -73.8% Jan 1, 2017 Dec 31, 2017 20-F 2020-03-31
2016 $9.11M +$23.8M Jan 1, 2016 Dec 31, 2016 20-F 2019-04-23
2015 -$14.7M -$14.7M -52045% Jan 1, 2015 Dec 31, 2015 20-F 2018-07-18
2014 -$28.3K Jan 1, 2014 Dec 31, 2014 20-F 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.